Cargando…

Potential for Molecular Testing for Group A Streptococcus to Improve Diagnosis and Management in a High-Risk Population: A Prospective Study

BACKGROUND: In high-burden settings, guidelines recommend antibiotic treatment for all suspected group A Streptococcus (GAS) infections to prevent rheumatic fever and poststreptococcal glomerulonephritis. Highly sensitive rapid GAS tests could reduce unnecessary antibiotic use in these settings. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Ralph, Anna P, Holt, Deborah C, Islam, Sharifun, Osowicki, Joshua, Carroll, David E, Tong, Steven Y C, Bowen, Asha C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469435/
https://www.ncbi.nlm.nih.gov/pubmed/31011589
http://dx.doi.org/10.1093/ofid/ofz097
_version_ 1783411641949356032
author Ralph, Anna P
Holt, Deborah C
Islam, Sharifun
Osowicki, Joshua
Carroll, David E
Tong, Steven Y C
Bowen, Asha C
author_facet Ralph, Anna P
Holt, Deborah C
Islam, Sharifun
Osowicki, Joshua
Carroll, David E
Tong, Steven Y C
Bowen, Asha C
author_sort Ralph, Anna P
collection PubMed
description BACKGROUND: In high-burden settings, guidelines recommend antibiotic treatment for all suspected group A Streptococcus (GAS) infections to prevent rheumatic fever and poststreptococcal glomerulonephritis. Highly sensitive rapid GAS tests could reduce unnecessary antibiotic use in these settings. METHODS: This was a prospective study of the Xpert Xpress Strep A (Cepheid) molecular test compared with culture of throat swab samples collected at a referral hospital in northern Australia. Demographic and clinical data and results of streptococcal serology and culture were collected. RESULTS: Of 164 throat swab samples, 145 (88%) were eligible for inclusion; 49 (34%) were molecular test positive and 24 (17%) were culture positive for GAS. The sensitivity, specificity, and positive and negative predictive values for the molecular test versus culture were 100.0%, 79.3%, 48.8%, and 100.0%, respectively. Among 25 samples testing positive with the molecular test and negative with culture, group C or G streptococci were cultured in 2, and a plausible clinical explanation, such as pharyngotonsillitis, or rheumatic fever with positive results of streptococcal serology, was apparent in 19 instances. In 25 patients with rheumatic fever or poststreptococcal glomerulonephritis diagnoses, molecular testing nearly trebled the detection of GAS in throat swab samples, from 3 (12%) detected with culture to 8 (32%) detected with molecular testing. Reasons for “false-positive” molecular test results could include the presence of GAS below the threshold of culture detection or persistence of nonviable organisms after infection. CONCLUSION: Implementation of molecular testing could improve antibiotic use in this high-burden setting. The incremental yield in poststreptococcal syndromes, by which time cultures are negative, has high potential in the diagnostic workup of autoimmune poststreptococcal syndromes and warrants further investigation.
format Online
Article
Text
id pubmed-6469435
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-64694352019-04-22 Potential for Molecular Testing for Group A Streptococcus to Improve Diagnosis and Management in a High-Risk Population: A Prospective Study Ralph, Anna P Holt, Deborah C Islam, Sharifun Osowicki, Joshua Carroll, David E Tong, Steven Y C Bowen, Asha C Open Forum Infect Dis Major Article BACKGROUND: In high-burden settings, guidelines recommend antibiotic treatment for all suspected group A Streptococcus (GAS) infections to prevent rheumatic fever and poststreptococcal glomerulonephritis. Highly sensitive rapid GAS tests could reduce unnecessary antibiotic use in these settings. METHODS: This was a prospective study of the Xpert Xpress Strep A (Cepheid) molecular test compared with culture of throat swab samples collected at a referral hospital in northern Australia. Demographic and clinical data and results of streptococcal serology and culture were collected. RESULTS: Of 164 throat swab samples, 145 (88%) were eligible for inclusion; 49 (34%) were molecular test positive and 24 (17%) were culture positive for GAS. The sensitivity, specificity, and positive and negative predictive values for the molecular test versus culture were 100.0%, 79.3%, 48.8%, and 100.0%, respectively. Among 25 samples testing positive with the molecular test and negative with culture, group C or G streptococci were cultured in 2, and a plausible clinical explanation, such as pharyngotonsillitis, or rheumatic fever with positive results of streptococcal serology, was apparent in 19 instances. In 25 patients with rheumatic fever or poststreptococcal glomerulonephritis diagnoses, molecular testing nearly trebled the detection of GAS in throat swab samples, from 3 (12%) detected with culture to 8 (32%) detected with molecular testing. Reasons for “false-positive” molecular test results could include the presence of GAS below the threshold of culture detection or persistence of nonviable organisms after infection. CONCLUSION: Implementation of molecular testing could improve antibiotic use in this high-burden setting. The incremental yield in poststreptococcal syndromes, by which time cultures are negative, has high potential in the diagnostic workup of autoimmune poststreptococcal syndromes and warrants further investigation. Oxford University Press 2019-02-26 /pmc/articles/PMC6469435/ /pubmed/31011589 http://dx.doi.org/10.1093/ofid/ofz097 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Major Article
Ralph, Anna P
Holt, Deborah C
Islam, Sharifun
Osowicki, Joshua
Carroll, David E
Tong, Steven Y C
Bowen, Asha C
Potential for Molecular Testing for Group A Streptococcus to Improve Diagnosis and Management in a High-Risk Population: A Prospective Study
title Potential for Molecular Testing for Group A Streptococcus to Improve Diagnosis and Management in a High-Risk Population: A Prospective Study
title_full Potential for Molecular Testing for Group A Streptococcus to Improve Diagnosis and Management in a High-Risk Population: A Prospective Study
title_fullStr Potential for Molecular Testing for Group A Streptococcus to Improve Diagnosis and Management in a High-Risk Population: A Prospective Study
title_full_unstemmed Potential for Molecular Testing for Group A Streptococcus to Improve Diagnosis and Management in a High-Risk Population: A Prospective Study
title_short Potential for Molecular Testing for Group A Streptococcus to Improve Diagnosis and Management in a High-Risk Population: A Prospective Study
title_sort potential for molecular testing for group a streptococcus to improve diagnosis and management in a high-risk population: a prospective study
topic Major Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469435/
https://www.ncbi.nlm.nih.gov/pubmed/31011589
http://dx.doi.org/10.1093/ofid/ofz097
work_keys_str_mv AT ralphannap potentialformoleculartestingforgroupastreptococcustoimprovediagnosisandmanagementinahighriskpopulationaprospectivestudy
AT holtdeborahc potentialformoleculartestingforgroupastreptococcustoimprovediagnosisandmanagementinahighriskpopulationaprospectivestudy
AT islamsharifun potentialformoleculartestingforgroupastreptococcustoimprovediagnosisandmanagementinahighriskpopulationaprospectivestudy
AT osowickijoshua potentialformoleculartestingforgroupastreptococcustoimprovediagnosisandmanagementinahighriskpopulationaprospectivestudy
AT carrolldavide potentialformoleculartestingforgroupastreptococcustoimprovediagnosisandmanagementinahighriskpopulationaprospectivestudy
AT tongstevenyc potentialformoleculartestingforgroupastreptococcustoimprovediagnosisandmanagementinahighriskpopulationaprospectivestudy
AT bowenashac potentialformoleculartestingforgroupastreptococcustoimprovediagnosisandmanagementinahighriskpopulationaprospectivestudy